Thanks for that info @Wallfly.Just so we're or I'm clear...

Thanks for that info @Wallfly.

Just so we're or I'm clear here..... This is an order purchased by Cannvalate from Valens that EPN have manufactured???

So under the recent agreement, EPN (THC Pharma) will pay Valens a management fee for this ~$500k order, yet they EPN take a royalty fee of 2.5% to 4% for all Valens customers.
Sounds like a money laundering operation to me, ha!

Hey @BobbyNorthcote, when was the last $5M purchase order in the Aus pot listed companies you've seen?
CAN claimed $15M in sales, but have since revised this down a couple times.


Note: reading the Valens Ann of 9th Sept again, medipharm platform yet to launch.

"The second agreement is a services agreement pursuant
to which Cannvalate will provide advice on matters including the launch of the Medimar platform,"